Bio-En Holdings Corp


Bio-En Holdings Corp

  • Price (USD)0.80
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Bio-En Holdings Corp is a shell company that is seeking to acquire an operating business. The Company’s business plan is to seek and identify a privately-held operating company desiring to become a publicly held company by combining with the Company through a reverse merger or acquisition type transaction. The Company has not involved in any business and not generated any revenue.

  • Revenue in USD (TTM)0.00
  • Net income in USD2.88k
  • Incorporated2011
  • Employees0.00
  • Location
    Bio-En Holdings Corp56 Main StMONSEY 10952-3011United StatesUSA
  • Phone+1 (845) 364-7151
  • Fax+1 (845) 818-3588
  • Websitehttp://bioenholding.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Model Performance Acquisition Corp-100.00bn-100.00bn57.50m----1.33----------7.51----------------------------0.0035--------------
AGBA Acquisition Ltd0.00-611.16k58.30m0.00--1.52-----0.1942-0.19420.007.180.00-------1.32---1.38--------------0.0628-------199.98------
HHG Capital Corp-100.00bn-100.00bn58.88m--------------------------------------------------------------
MFS Intermediate High Income Fund-100.00bn-100.00bn58.88m--------------------------------------------------------------
Pimco NY Muni. Income Fund III-100.00bn-100.00bn59.20m--------------------------------------------------------------
Kemiao Garment Holding Group0.00-59.76k60.09m-----------0.2471-0.24710.00-0.0011-------------------------------------100.45------
First Trust Spclty Fin & Fncl Opptnts Fd-100.00bn-100.00bn60.34m--------------------------------------------------------------
Venus Acquisition Corp-100.00bn-100.00bn60.86m----1.35----------7.44----------------------------0.00002-------2,265.26------
New Ireland Fund Inc-100.00bn-100.00bn61.15m0.00------------------------------------------------------------
Ace Global Business Acquisition Ltd-100.00bn-100.00bn61.57m----1.38----------7.35----------------------------0.00--------------
Bio-En Holdings Corp0.002.88k61.88m0.0020,000.00------0.000040.000040.00-0.00590.00------22.91-57.77-------------------------102.16------
Brilliant Acquisition Corp0.00-359.41k61.97m----1.34-----0.0588-0.05880.007.550.00-------0.7649---0.7742-------------2.440.00-------1,437.95------
Delaware Investments Natnl Mncpl Incm Fd-100.00bn-100.00bn63.27m--------------------------------------------------------------
Neuberger Berman New York Muncipl Fd Inc-100.00bn-100.00bn64.28m--------------------------------------------------------------
SPK Acquisition Corp-100.00bn-100.00bn64.97m----1.32----------7.45----------------------------0.0025--------------
Petra Acquisition Inc0.00-1.78m66.19m2.00--0.2716-----0.2441-0.24410.0037.190.00----0.00-4.80---5.03-------------328.500.00-------44,693.96------
Data as of --. Currency figures normalised to Bio-En Holdings Corp's reporting currency: US Dollar USD
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.